Clinical markers of asthma

Thematic Poster
Chairs: C. Leroyer (Brest, France), A. Cruz (Salvador (BA), Brazil), C. Begne (Periguex, France), H. Backman (Lulea, Sweden)

Loss of smell: a clinical marker of severe asthma J. Castillo Vizuete (Barcelona, Spain), C. Picado (Barcelona, Spain), V. Plaza (Barcelona, Spain), G. Rodrigo (Montevideo, Uruguay), B. Juliá (Madrid, Spain), C. Fernandez (Madrid, Spain), J. Mullol (Barcelona , Spain)
Chronic hyperventilation in Asthma D. Deenstra (Eindhoven, Netherlands), H. Van Helvoort (Nijmegen, Netherlands), N. Koolen (Nijmegen, Netherlands), R. Djamin (Breda, Netherlands), J. Antons (Nijmegen, Netherlands), A. Van 'T Hul (Nijmegen, Netherlands)
One-year follow-up of asthma patients in a randomised controlled trial of high-intensity training. Are there lasting effects? A. Bentzon (Copenhagen, Denmark), L. Loehde (Copenhagen, Denmark), L. Toennesen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark), M. Hostrup (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark)
Correlation between reduced  forced expiratory flow between 25% and 75% (FEF 25-75%) and a positive methacholine challenge test (MCT) in adults with non-obstructive baseline spirometry. I. Shafiq (Abu Dhabi, United Arab Emirates), A. Wahla (Abu Dhabi, United Arab Emirates), M. Uzbeck (Abu Dhabi, United Arab Emirates), N. Parappurath (Abu Dhabi, United Arab Emirates), Z. Zoumot (Abu Dhabi, United Arab Emirates)
Clinical and histhologic effect of bronchial thermoplasty after 1 year R. Piro (Reggio Emilia, Italy), C. Galeone (Reggio Emilia, Italy), F. Menzella (Reggio Emilia, Italy), P. Ruggiero (Reggio Emilia, Italy), M. Lusuardi (Reggio Emilia, Italy), N. Facciolongo (Reggio Emilia, Italy)
Quality of sleep in asthmatic patients A. Pallares Sanmartin (Vigo, Spain), A. Sogo Sagardia (Sabadell, Spain), M. González Gutiérrez (Mataró, Spain), A. Crespo Lessman (Barcelona, Spain), N. Marina Malanda (Bilbao, Spain), R. Andújar Espinosa (Murcia, Spain), M. Ferrer Galván (Sevilla, Spain), A. Boldova Loscertales (Zaragoza, Spain), S. Herrera Lara (Valencia, Spain), L. Vigil Gimenez (Sabadell, Spain), J. Serrano Pariente (Inca, Spain), C. Cisneros Serrano (Madrid, Spain), A. López Viñas (Madrid, Spain), C. Picado Vallés (Barcelona, Spain), V. Plaza Moral (Barcelona, Spain)
Evaluation of pulmonary function after bronchial thermoplasty in the treatment of severe uncontrolled asthma using forced oscillation technique. Y. Shimoda (Tokyo, Japan), M. Iikura (Tokyo, Japan), K. Sakamoto (Yokyo, Japan), M. Hashimoto (Tokyo, Japan), S. Ishii (Tokyo, Japan), S. Izumi (Tokyo, Japan), M. Hojo (Tokyo, Japan), H. Sugiyama (Tokyo, Japan)
Factors that determine the success of step-up therapy in uncontrolled asthmatic patients in clinical practice A. Mogrovejo Calle (Valencia, Spain), E. Martínez Moragón (Valencia, Spain), J. Delgado Romero (Sevilla, Spain), M. Pérez Estrada Cornejo (Sevilla, Spain), I. García Nunez (Cadiz, Spain), A. Crespo Sedano (Sevilla, Spain), A. Soto Vanegas (Jaen, Spain)
Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort F. Alahmadi (Manchester, United Kingdom), A. Simpson (Hull, United Kingdom), C. Gomez (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), D. Shaw (Nottingham, United Kingdom), L. Fleming (London, United Kingdom), G. Roberts (Southampton, United Kingdom), J. Riley (London, United Kingdom), S. Bates (London, United Kingdom), A. Sousa (London, United Kingdom), R. Knowles (Stevenage, United Kingdom), A. Bansal (Cambridge, United Kingdom), J. Corfield (Mölndal, Belgium), I. Pandis (London, United Kingdom), K. Sun (London, United Kingdom), P. Bakke (Bergen, Norway), M. Caruso (Catania, Italy), P. Chanez (Marseille, France), B. DahléN (Stockholm, Sweden), I. Horvath (Budapest, Hungary), N. Krug (Hannover, Germany), P. Montuschi (Milan, Italy), T. Sandstrom (Umeå, Sweden), F. Singer (Bern, Switzerland), S. Wagers (Maasmechelen, Belgium), I. Adcock (London, United Kingdom), R. Djukanovic (Southampton, United Kingdom), K. Chung (London, United Kingdom), P. Sterk (Amsterdam, Netherlands), S. Dahlen (Stockholm, Sweden), S. Fowler (Manchester, United Kingdom)
The association of vigorous physical activity with 10-year adult asthma incidence M. Russell (Melbourne, Australia), S. Dharmage (Melbourne, Australia), E. Fuertes (Barcelona, Spain), D. Jarvis (London, United Kingdom), M. Abramson (Melbourne, Australia), J. Heinrich (Munich, Germany), A. Johannessen (Bergen, Norway), B. Lenaert (Paris, France), A. Marcon (Verona, Italy), N. Probst (Basel, Switzerland), C. Raherison (Bordeaux, France), G. Squillacioti (Turin, Italy), J. Sánchez-Ramos (Huelva, Spain), J. Sommar (Umeå, Sweden), J. Garcia Aymerich (Barcelona, Spain)
Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma L. Tuomisto (Seinäjoki, Finland), P. Ilmarinen (Seinäjoki, Finland), L. Lehtimaki (Tampere, Finland), M. Tommola (Seinäjoki, Finland), H. Kankaanranta (Seinäjoki and Tampere, Finland)
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management M. Hvidtfeldt (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
Two phenothypes of severe asthma identified by cluster analysis O. Kharevich (Minsk, Belarus), I. Lapteva (Minsk, Belarus), E. Lapteva (Minsk, Belarus)
Changes of the blood pressure in asthmatics of different age groups in response to short-time cold air airway challenge A. Prikhodko (Blagoveshchensk, Russian Federation), J. Perelman (Blagoveshchensk, Russian Federation)
Switch from Symbicort Turbuhaler to Bufomix Easyhaler; a real-life prospective study in asthma patients P. Rytilä (Espoo, Finland), J. Syk (Stockholm, Sweden), I. Vinge (Lidingö, Sweden), M. Sörberg (Sollentuna, Sweden)
Patterns of sensitization to furry animal allergen components in adult asthma and indicators of severity B. Nwaru (Gothenburg, Sweden), S. Suzuki (Tokyo, Japan), L. Ekerljung (Gothenburg, Sweden), S. Sjölander (Uppsala, Sweden), R. Mincheva (Gothenburg, Sweden), E. Rönmark (Gothenburg, Sweden), E. Rönmark (Umeå, Sweden), M. Borres (Uppsala, Sweden), B. Lundbäck (Gothenburg, Sweden), J. Lötvall (Gothenburg, Sweden)
Incremental cost-effective ratio effect of Omalizumab treatment for Severe Allergic Asthma at Danish university Hospital. S. Petersen (Aalborg, Denmark), U. MøLler Weincreich (Aalborg, Denmark)
Dynamic hyperinflation predicts impaired daily life activity in asthma A. van der Meer (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), E. Bel (Amsterdam, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
SABA overuse in the Portuguese prescription database A. Sá-Sousa (Porto, Portugal), R. Almeida (Porto, Portugal), A. Freitas (Porto, Portugal), J. Almeida Fonseca (Porto, Portugal)
Association between vitamin D deficiency and risk of uncontrolled asthma development V. Kupaev (Samara, Russian Federation), M. Nurdina (Samara, Russian Federation)